KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$25.1 million.

  • BioNTech SE's Exchange Rate Effect fell 89507.64% to -$25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.1 million, marking a year-over-year decrease of 1219.54%. This contributed to the annual value of $15.8 million for FY2024, which is 20137.22% up from last year.
  • Per BioNTech SE's latest filing, its Exchange Rate Effect stood at -$25.1 million for Q3 2025, which was down 89507.64% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Exchange Rate Effect ranged from a high of $865.0 million in Q4 2022 and a low of -$105.2 million during Q4 2021
  • Over the past 5 years, BioNTech SE's median Exchange Rate Effect value was $7.4 million (recorded in 2024), while the average stood at $64.1 million.
  • In the last 5 years, BioNTech SE's Exchange Rate Effect crashed by 19189470776.36% in 2021 and then soared by 19597969446.1% in 2022.
  • Quarter analysis of 5 years shows BioNTech SE's Exchange Rate Effect stood at -$105.2 million in 2021, then skyrocketed by 921.86% to $865.0 million in 2022, then plummeted by 101.92% to -$16.6 million in 2023, then surged by 187.71% to $14.5 million in 2024, then tumbled by 272.95% to -$25.1 million in 2025.
  • Its Exchange Rate Effect stands at -$25.1 million for Q3 2025, versus $10.4 million for Q2 2025 and -$16.9 million for Q1 2025.